Abbott Overview

  • Year Founded
  • 1888

Year Founded

  • Status
  • Public

  • Employees
  • 114,000

Employees

  • Stock Symbol
  • ABT

Stock Symbol

  • Investments
  • 68

  • Share Price
  • $119.02
  • (As of Thursday Closing)

Abbott General Information

Description

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Contact Information

Website
www.abbott.com
Formerly Known As
Alere Technologies, Alere Technologies GmbH
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Monitoring Equipment
Diagnostic Equipment
Stock Exchange
NYS
Corporate Office
  • 100 Abbott Park Road
  • Abbott Park
  • North Chicago, IL 60064
  • United States
+1 (224) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abbott Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$119.02 $117.87 $89.67 - $119.25 $207B 1.74B 5.38M $3.28

Abbott Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 199,781,963 199,781,963 198,142,965 257,789,708
Revenue 40,109,000 40,109,000 43,653,000 43,075,000
EBITDA 10,159,000 10,159,000 11,948,000 12,239,000
Net Income 5,723,000 5,723,000 6,933,000 7,071,000
Total Assets 73,214,000 73,214,000 74,438,000 75,196,000
Total Debt 15,628,000 15,628,000 17,716,000 19,006,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Abbott Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abbott‘s full profile, request access.

Request a free trial

Abbott Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnosti
Pharmaceuticals
North Chicago, IL
114,000 As of 2023
000.00
000000000 00 000.00

0000 0

a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
000000000000000
Bagsvaerd, Denmark
00000 As of 0000
000000000

000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magn
0000000000000
South San Francisco, CA
00000 As of 0000
00.000
0000 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abbott Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novo Nordisk Corporation Bagsvaerd, Denmark 00000 000000000
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Coloplast Corporation Humlebaek, Denmark 00000 00.000 000000000 00.000
Medtronic Corporation Minneapolis, MN 00000 000.00 000000000 00 000.00
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria 00 00000000
You’re viewing 5 of 13 competitors. Get the full list »

Abbott Patents

Abbott Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240009430-A1 Guidewire core having non-round cross-sections Pending 08-Jul-2022 000000000
US-20240003916-A1 Magnetic point-of-care systems and assays for determining gfap in biological samples Pending 29-Jun-2022 00000000000
US-20230399725-A1 Processing of cobalt-tungsten alloys Pending 08-Jun-2022 000000000
US-20230391491-A1 Reclosable plastic bottle with waist and strengthening rib(s) Pending 03-Jun-2022 00000000 0
US-20230240871-A1 Stent delivery handle assembly Pending 03-Feb-2022 A61F2/9517
To view Abbott’s complete patent history, request access »

Abbott Executive Team (102)

Name Title Board Seat Contact Info
Robert Ford Chief Executive Officer, Chairman of the Board, and Member of the Executive Committee
Lisa Earnhardt Executive Vice President, Medical Devices
Philip Boudreau Senior Vice President, Finance, and Chief Financial Officer
Melissa Brotz Chief Marketing and Communications Officer
Josef McNeal Commercial Sales & Marketing Director, U.S. Operations (Health Tech and Innovation)
You’re viewing 5 of 102 executive team members. Get the full list »

Abbott Board Members (22)

Name Representing Role Since
000000 000000000-0 Self Board Member, Member of the Public Policy Committee and Member of Audit Committee 000 0000
000000 000000 00 Abbott Board Member, Chairman of the Compensation Committee and Member of Executive and Public Policy Committee 000 0000
000000 00000 Self Board Member and Member of Nomination and Governance Committee & Public Policy Committee 000 0000
0000 00000000 Self Board Member, Chairman of the Nominations and Governance Committee and Member of Audit Committee & Executive Committee 000 0000
0000000 0'00000 Self Board Member and Member of Compensation Committee, Nominations & Governance Committee 000 0000
You’re viewing 5 of 22 board members. Get the full list »

Abbott Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abbott Investments & Acquisitions (68)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bigfoot Biomedical 22-Sep-2023 0000000000 Monitoring Equipment 00000 000
Allergy Therapeutics 14-Jul-2023 000000000 Pharmaceuticals
Cardiovascular Systems 27-Apr-2023 0000000000 00000 Surgical Devices 0000 0000
Kurbo Health 01-Mar-2023 0000000000 000 Other Services (B2C Non-Financial)
Walk Vascular 02-Sep-2021 Merger/Acquisition Therapeutic Devices 00000 000
You’re viewing 5 of 68 investments and acquisitions. Get the full list »

Abbott Subsidiaries (13)

Company Name Industry Location Founded
Bigfoot Biomedical Monitoring Equipment Milpitas, CA 2014
Topera Diagnostic Equipment Menlo Park, CA 0000
Abbott Ventures Corporate Venture Capital Lake County, IL 0000
Abbott Laboratories Pension Plan for Former Basf and Former Solvay employees Corporate Pension North Chicago, IL 0000
Visiogen Therapeutic Devices Irvine, CA 0000
You’re viewing 5 of 13 subsidiaries. Get the full list »

Abbott ESG

Risk Overview

Risk Rating

Updated January, 23, 2024

25.01 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,605

Rank

00.0

Percentile

Healthcare

Industry

00 of 606

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 210

Rank

00.00

Percentile

To view Abbott’s complete esg history, request access »

Abbott Exits (12)

Company Name Exit Date Exit Type Exit Size Status Buyers
Allergy Therapeutics 14-Jul-2023 000000000 00000000 Completed
  • 3 buyers
Dairy Farming (Fonterra / Abbott) 11-Jul-2014 00000 0000000 00000 Completed
  • 2 buyers
Starlims Technologies 22-Mar-2010 000000000000000000 00000 Completed
  • 000000
VytronUS 29-Jun-2009 00000 00000 00 0000 Completed
  • 3 buyers
Abbott Medical Optics 01-Jan-2009 Merger/Acquisition 00.00 Completed
You’re viewing 5 of 12 exits. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »